Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease

scientific article published on 01 September 2012

Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5301/EJO.5000117
P698PubMed publication ID22287172

P50authorChristophe BaudouinQ37616711
Pascale PouliquenQ123123975
P2093author name stringBéatrice Cochener
Catherine Creuzot-Garcher
Pierre-Jean Pisella
Hazel Cooper
Brigitte Girard
P433issue5
P921main subjecteye diseaseQ3041498
P304page(s)751-761
P577publication date2012-09-01
P1433published inEuropean Journal of OphthalmologyQ15755023
P1476titleRandomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease
P478volume22

Reverse relations

cites work (P2860)
Q33800709A prospective, multicenter, noninterventional study of Optive Plus(®) in the treatment of patients with dry eye: the prolipid study
Q34474379A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome
Q55250864Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis.
Q33553643Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
Q35507058Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial
Q36280601Efficacy of Carboxymethylcellulose and Hyaluronate in Dry Eye Disease: A Systematic Review and Meta-Analysis
Q36362131Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model
Q35843885In Vivo and Impression Cytology Study on the Effect of Compatible Solutes Eye Drops on the Ocular Surface Epithelial Cell Quality in Dry Eye Patients
Q41817907Investigating the potential benefits of a new artificial tear formulation combining two polymers
Q42947645Lipid-containing osmoprotective eye drops in contact lens wearers
Q64106425Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
Q42702543Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye.
Q24186110Over the counter (OTC) artificial tear drops for dry eye syndrome
Q43119649Relevance of Lipid-Based Products in the Management of Dry Eye Disease
Q57471627Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas
Q41489266Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis
Q36811289The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy
Q38270449The role and treatment of inflammation in dry eye disease

Search more.